Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
The Chancellor, Masters, Scholars Of The University Of Oxford investment portfolio
The Chancellor, Masters, Scholars Of The University Of Oxford has made numerous investments in companies such as Osler Diagnostics, Omass Therapeutics, and Brill Power within the Biotech sector.
university
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Brill Power Limited | Healthcare & Life Sciences | Confirmed | 2025-06-08 |
| Omass Therapeutics Limited OMASS THERAPEUTICS LIMITED is a biotechnology company that develops small molecule therapeutics for orphan diseases and immunological conditions. The company targets patients with immunological disorders and rare diseases, and operates in Europe, North America, and Asia, engaging with healthcare providers, pharmaceutical companies, and research institutions. | Healthcare & Life Sciences | Confirmed | 2026-03-12 |
Shareholding changes (3)
The Chancellor, Masters, Scholars Of The University Of Oxford's positions across portfolio companies2025
- SERIES A2 13,986 → 0
- SERIES A3 0 → 13,986
2024
- ORDINARY 0 → 59,400
- SERIES A2 0 → 13,986
Articles (1)
- 25 May 2026